See also

References

1. ^^abManas ES, MewshawRE, Harris HA, Malamas MS (2006)."Isoform Specificity: The Design of Estrogen Receptor-β Selective Compounds". In Hubbard RE (ed.).Structure-based Drug Discovery: An Overview. Royal Society of Chemistry. pp. 241–.ISBN 978-0-85404-351-4.
2. ^^ab"ERB 196".AdisInsight. Springer Nature Switzerland AG. Archived fromthe original on 25 June 2018. Retrieved15 January 2022.
3. ^Acton QA (2013)."Estradiol".Estrogens—Advances in Research and Application. ScholarlyEditions. pp. 52–.ISBN 978-1-4816-8771-3.
4. ^Weatherman RV (8 September 2008)."Untangling the Estrogen Receptor Web: Tools to Selectively Study Estrogen-Binding Receptors". In Ottow E, Weinmann H (eds.).Nuclear Receptors as Drug Targets. Methods and Principles in Medicinal Chemistry. John Wiley & Sons. pp. 66–.doi:10.1002/9783527623297.ch3.ISBN 978-3-527-62330-3.
5. ^Mewshaw RE, Edsall RJ, Yang C, Manas ES, Xu ZB, Henderson RA, et al. (June 2005). "ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity".Journal of Medicinal Chemistry.48 (12):3953–3979.doi:10.1021/jm058173s.PMID 15943471.
6. ^Cristofaro PA, Opal SM, Palardy JE, Parejo NA, Jhung J, Keith JC, Harris HA (August 2006). "WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock".Critical Care Medicine.34 (8):2188–2193.doi:10.1097/01.CCM.0000227173.13497.56.PMID 16755255.S2CID 20876539.
7. ^Adrie C, Azoulay E, Timsit JF (8 December 2007)."Influence of Gender on Outcome of Severe Sepsis". In Vincent JL (ed.).Yearbook of Intensive Care and Emergency Medicine 2007. Springer Science & Business Media. pp. 891–.ISBN 978-3-540-49433-1.

External links